The game’s afoot for CRISPR diagnostic developer Sherlock Biosciences. The company hopes to speed up its path to market through the acquisition of the rapid test maker Sense Biodetection. Based in ...

Programmable CRISPR tools are turning stem cell biology into something closer to software engineering, shrinking ...

Originally developed for gene editing, CRISPR-Cas systems have now become powerful molecular diagnostic tools. However, their widespread adoption in diagnostics has relied heavily on traditional ...

Schematic illustration of nucleic acid detection by the conventional CRISPR assay and the asymmetric CRISPR assay. Credit: Nature Communications (2023). DOI: 10.1038/s41467-023-43389-7 Changchun Liu, ...

Coronavirus Disease 2019 (COVID-19) has driven the use of nucleic acid testing technology in clinical testing. There is a growing need for point-of-care testing (POCT) devices that can integrate ...

The COVID pandemic was a make or break moment for many a biotech. At Mammoth Biosciences, it may have been a little of both. For Janice Chen, Ph.D., the CRISPR biotech's chief technology officer and ...

Bengaluru-based biotechnology startup CrisprBits Private Limited has raised USD 3 Million through founders, angels & family offices, bringing the company's valuation to $12 Million. The current Pre-Se ...

Researchers have developed a fast, specific and reliable test for mpox infection, combining CRISPR/Cas12a and nanopore sensing. Research presented at the 68th Biophysical Society Annual Meeting (10-14 ...

Preeminent IP position gives Sherlock freedom to operate and commercialize across multiple CRISPR business avenues WATERTOWN, Mass., Feb. 21, 2023 /PRNewswire/ -- Sherlock Biosciences, a company ...

Overview of CRISPR/Cas system-based tumor molecular diagnostic strategies, including variant gene, protein, and liquid biopsy marker assays and in situ molecular analysis. The CRISPR/Cas system, known ...